Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi Institutional Study To Evaluate Dna Methlyation Markers For Detection Of Primary Bladder Cancer In Urine Samples From A Cohort Of Patients With Hematuria

NCT03122964 is registered in ClinicalTrials.gov with MDx Health as lead sponsor.

NCT NCT03122964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03122964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi Institutional Study To Evaluate Dna Methlyation Markers For Detection Of Primary Bladder Cancer In Urine Samples From A Cohort Of Patients With Hematuria
Lead sponsor
MDx Health
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2017
Completion date
February 28, 2020
Enrollment
1,148 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, hematuria